1Iconix Biosciences, Inc., Molecular and Investigative Toxicology, 325 E Middlefield Road, Mountain View, CA 94043, USA. mfielden@iconixbiosciences.com
View abstract on PubMed
Iconix Biosciences utilizes proprietary genomic technologies for faster, cost-effective drug candidate profiling. This toxicogenomics approach enhances toxicity testing accuracy and speed, aiming to reduce late-stage failures in drug development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: